Khamees Ibrahim, Ali Elrazi A, Malkawi Lujain, Rozi Waail, Yassin Mohamed A
Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Internal Medicine, Interfaith Medical Center/One Brooklyn Health, Brooklyn, USA.
Cureus. 2022 Nov 30;14(11):e32041. doi: 10.7759/cureus.32041. eCollection 2022 Nov.
The Coronavirus disease 2019 (COVID-19) is considered the largest pandemic in modern history. Since the first case was reported in 2019, several mutations have affected the severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2), resulting in the emergence of new strains. These strains vary significantly in severity and transmissibility. The Omicron (B.1.1.529) variant was reported to cause mild disease in those affected, but little is known about the effect of Omicron on patients with chronic lymphocytic leukemia (CLL). We are reporting a case series of three patients with CLL who experienced infection with the SARS-CoV-2 Omicron variant and their outcomes.
2019年冠状病毒病（COVID-19）被认为是现代历史上最大的大流行病。自2019年报告首例病例以来，几种突变影响了严重急性呼吸综合征冠状病毒2（SARS-CoV-2），导致新毒株出现。这些毒株在严重程度和传播性上有很大差异。据报道，奥密克戎（B.1.1.529）变种在感染者中引起的疾病较轻，但关于奥密克戎对慢性淋巴细胞白血病（CLL）患者的影响知之甚少。我们报告了一组3例感染了SARS-CoV-2奥密克戎变种的CLL患者及其治疗结果。
